Telix Pharmaceuticals TLX Peer Comparison

NASDAQ TLX
$11.89 +0.15 (+1.28%)
As of: Sep 4, 2026 · 10:51 AM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

Telix Pharmaceuticals Ltd (TLX) is the 47th largest of 300 Biotechnology companies by market capitalisation, at 4.02 Bn, behind Dianthus Therapeutics, Inc. /DE/ at 4.06 Bn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 236.10 Bn 0.00 Mn 6.20 222.12 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 186.69 Bn 0.00 Mn 6.13 183.51 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 139.68 Bn 0.00 Mn 11.10 131.82 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 85.68 Bn 0.00 Mn 5.52 77.68 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 63.67 Bn 0.00 Mn 12.18 58.48 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 57.02 Bn 0.00 Mn 25.59 51.88 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 35.23 Bn 0.00 Mn 7.33 31.93 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 32.52 Bn 0.00 Mn 3.24 31.24 Bn
9 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.54 Bn 0.00 Mn 24.21 26.38 Bn
10 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 25.03 Bn 0.00 Mn 8.09 11.37 Bn
11 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 24.69 Bn 0.00 Mn 2,260.06 24.69 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 16.12 Bn 0.00 Mn 13.20 15.18 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.70 Bn 0.00 Mn 12.23 14.86 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.54 Bn 0.00 Mn 20.39 13.82 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.35 Bn — — 12.66 Bn
16 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.84 Bn 0.00 Mn 7.72 12.61 Bn
17 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.74 Bn 0.00 Mn 3.74 11.87 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.19 Bn 0.00 Mn 18.21 10.59 Bn
19 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.28 Bn 0.00 Mn — 9.53 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn 0.00 Mn — 9.20 Bn
21 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.69 Bn 0.00 Mn 34.35 9.69 Bn
22 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.63 Bn 0.00 Mn 11.02 7.58 Bn
23 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.86 Bn 0.00 Mn — 8.86 Bn
24 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.48 Bn 0.00 Mn 51.18 8.13 Bn
25 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.99 Bn 0.00 Mn — 7.99 Bn
26 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.92 Bn 0.00 Mn 9.90 7.23 Bn
27 ABVX Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.85 Bn 0.00 Mn — 7.85 Bn
28 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.38 Bn 0.00 Mn — 7.38 Bn
29 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.24 Bn 0.00 Mn — 7.24 Bn
30 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.08 Bn 0.00 Mn 29.52 6.75 Bn
31 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.53 Bn 0.00 Mn 4,693.23 6.53 Bn
32 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.48 Bn 0.00 Mn 1,040.75 6.48 Bn
33 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.45 Bn 0.00 Mn 10.43 6.01 Bn
34 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 6.23 Bn 0.00 Mn 7.41 5.70 Bn
35 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.95 Bn 0.00 Mn — 5.95 Bn
36 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.94 Bn 0.00 Mn — 5.94 Bn
37 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn — — 4.09 Bn
38 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn 0.00 Mn 5.77 3.59 Bn
39 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.79 Bn 0.00 Mn 1,154.02 5.62 Bn
40 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 0.00 Mn 19.89 4.42 Bn
41 GRFS Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 5.30 Bn 0.00 Mn 0.32 4.14 Bn
42 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.20 Bn 0.00 Mn — 5.20 Bn
43 RADX Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 5.08 Bn 0.00 Mn 20,980.03 5.08 Bn
44 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.05 Bn 0.00 Mn — 5.05 Bn
45 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.16 Bn 0.00 Mn 1,155.38 4.16 Bn
46 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn — — 3.66 Bn
47 TLX Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn — — 3.73 Bn
48 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.01 Bn 0.00 Mn — 4.01 Bn
49 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.96 Bn 0.00 Mn — 3.96 Bn
50 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.84 Bn 0.00 Mn 371.40 3.84 Bn
51 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.75 Bn 0.00 Mn — 3.75 Bn
52 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.73 Bn 0.00 Mn 31.85 3.02 Bn
53 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.66 Bn 0.00 Mn 15.64 2.83 Bn
54 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.49 Bn 0.00 Mn 52.73 3.49 Bn
55 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.34 Bn 0.00 Mn 62.12 2.33 Bn
56 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.10 Bn 0.00 Mn 6.68 2.86 Bn
57 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.07 Bn 0.00 Mn — 3.07 Bn
58 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.05 Bn 0.00 Mn 19,312.20 3.05 Bn
59 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.04 Bn 0.00 Mn 593.06 2.52 Bn
60 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.92 Bn 0.00 Mn — 2.92 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.88 Bn 0.00 Mn 6.41 2.17 Bn
62 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.85 Bn 0.00 Mn 77.47 2.40 Bn
63 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.63 Bn 0.00 Mn — 2.63 Bn
64 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.56 Bn 0.00 Mn — 2.56 Bn
65 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.52 Bn 0.00 Mn 4.71 2.17 Bn
66 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn 0.00 Mn 44.72 1.76 Bn
67 HCM HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.42 Bn 0.00 Mn 3.41 2.42 Bn
68 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn 0.00 Mn 46.18 2.40 Bn
69 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.39 Bn 0.00 Mn 33.62 2.39 Bn
70 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.33 Bn 0.00 Mn — 2.06 Bn
71 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.26 Bn 0.00 Mn — 2.26 Bn
72 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn 0.00 Mn — 2.25 Bn
73 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn 0.00 Mn 11.81 2.12 Bn
74 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn 0.00 Mn 111.02 2.22 Bn
75 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn 0.00 Mn 0.34 0.69 Bn
76 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.00 Mn 58.20 1.89 Bn
77 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 0.00 Mn 4.20 2.02 Bn
78 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.11 Bn 0.00 Mn — 1.74 Bn
79 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn 0.00 Mn 2,077.34 2.08 Bn
80 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.02 Bn 0.00 Mn 19.20 1.64 Bn
81 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn 0.00 Mn 20.06 1.97 Bn
82 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.95 Bn 0.00 Mn 70.65 1.66 Bn
83 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn 0.00 Mn 35.24 1.38 Bn
84 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.90 Bn 0.00 Mn 1,464.81 1.90 Bn
85 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.90 Bn 0.00 Mn 6.27 1.90 Bn
86 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn 0.00 Mn 4.38 1.00 Bn
87 LKFT Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.88 Bn 0.00 Mn 1.63 1.88 Bn
88 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.84 Bn 0.00 Mn 7.30 1.29 Bn
89 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.81 Bn 0.00 Mn — 1.81 Bn
90 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn 0.00 Mn — 1.77 Bn
91 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn 0.00 Mn 1,025.06 1.76 Bn
92 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn 0.00 Mn — 1.34 Bn
93 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn 0.00 Mn — 1.14 Bn
94 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn 0.00 Mn 4.03 0.95 Bn
95 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn 0.00 Mn 16.71 1.65 Bn
96 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.62 Bn 0.00 Mn 8.15 1.34 Bn
97 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn 0.00 Mn 525.18 1.59 Bn
98 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn 0.00 Mn 2.22 1.30 Bn
99 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn 0.00 Mn — 1.23 Bn
100 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn 0.00 Mn — 1.57 Bn
101 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn 0.00 Mn 20.12 1.29 Bn
102 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.56 Bn 0.00 Mn — 1.56 Bn
103 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.55 Bn 0.00 Mn 77.49 1.55 Bn
104 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn 0.00 Mn — 1.46 Bn
105 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn 0.00 Mn — 1.45 Bn
106 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn 0.00 Mn 172.91 0.94 Bn
107 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn 0.00 Mn 50.04 0.80 Bn
108 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.41 Bn 0.00 Mn 904.88 1.21 Bn
109 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 0.00 Mn 35.97 1.38 Bn
110 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
111 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
112 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn 0.00 Mn — 1.35 Bn
113 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn 0.00 Mn — 1.12 Bn
114 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.32 Bn 0.00 Mn — 1.32 Bn
115 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn 0.00 Mn 52.05 1.25 Bn
116 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn 0.00 Mn 3.17 1.14 Bn
117 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.23 Bn 0.00 Mn — 1.23 Bn
118 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.19 Bn 0.00 Mn — 1.19 Bn
119 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn 0.00 Mn — 0.57 Bn
120 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 1.06 Bn 0.00 Mn — 1.06 Bn
121 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn — 0.96 Bn
122 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn 5.55 0.92 Bn
123 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn 0.00 Mn 4.10 0.70 Bn
124 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn 0.00 Mn 14.95 0.61 Bn
125 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn 0.00 Mn — 0.97 Bn
126 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.92 Bn 0.00 Mn 2.05 0.64 Bn
127 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.90 Bn 0.00 Mn 3.24 0.80 Bn
128 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 8.46 0.49 Bn
129 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 881.85 0.88 Bn
130 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn 0.00 Mn 102.64 0.84 Bn
131 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn 0.00 Mn — 0.84 Bn
132 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn 0.00 Mn 2.35 0.62 Bn
133 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn 0.00 Mn 42.35 0.44 Bn
134 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.76 Bn 0.00 Mn — 0.76 Bn
135 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 0.00 Mn — 0.49 Bn
136 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 0.00 Mn — 0.64 Bn
137 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 0.00 Mn 1.80 0.62 Bn
138 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 0.00 Mn 1,126.77 0.62 Bn
139 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.68 Bn 0.00 Mn 9.05 0.36 Bn
140 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 0.00 Mn — 0.65 Bn
141 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 0.00 Mn 615.35 0.47 Bn
142 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -0.36 Mn — 0.34 Bn
143 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 0.00 Mn 1.92 0.04 Bn
144 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 0.00 Mn — 0.61 Bn
145 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn 0.00 Mn 15.34 0.54 Bn
146 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn 557.47 Mn 3.51 0.44 Bn
147 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 0.00 Mn — 0.57 Bn
148 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn 0.00 Mn — 0.56 Bn
149 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn 0.00 Mn — 0.55 Bn
150 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.53 Bn 0.00 Mn 23.56 0.25 Bn
151 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn 9.22 0.21 Bn
152 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn — 0.50 Bn
153 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 78.36 0.26 Bn
154 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.54 0.42 Bn
155 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn 0.00 Mn 13.75 0.23 Bn
156 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn 0.00 Mn 2.06 0.38 Bn
157 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.47 Bn
158 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.45 Bn
159 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.47 Bn
160 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.24 Bn
161 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn 15.13 0.25 Bn
162 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn — 0.44 Bn
163 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn 0.00 Mn 43.42 0.23 Bn
164 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn 0.00 Mn 40.92 0.42 Bn
165 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn 0.00 Mn 6.23 0.22 Bn
166 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn 142.43 0.22 Bn
167 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn — 0.24 Bn
168 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
169 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn 0.00 Mn — 0.37 Bn
170 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn 9.36 0.28 Bn
171 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn — 0.34 Bn
172 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn 2.53 0.34 Bn
173 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 3.71 0.17 Bn
174 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 104.71 0.33 Bn
175 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
176 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 63.88 0.30 Bn
177 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
178 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 4.85 0.30 Bn
179 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn — 0.29 Bn
180 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 13.10 0.29 Bn
181 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn 19.94 0.10 Bn
182 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.27 Bn
183 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.27 Bn
184 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn 1.61 0.16 Bn
185 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 62.45 0.26 Bn
186 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.16 Bn
187 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.14 Bn
188 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.26 Bn
189 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 4.54 0.10 Bn
190 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 22.22 0.26 Bn
191 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn 18.06 0.22 Bn
192 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn — 0.25 Bn
193 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn — 0.24 Bn
194 YDES YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 287.04 0.24 Bn
195 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 3.24 0.15 Bn
196 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
197 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
198 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
199 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 6.72 -0.04 Bn
200 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 10.22 0.08 Bn
201 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
202 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 90.68 0.10 Bn
203 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 4.24 0.11 Bn
204 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 32.66 0.21 Bn
205 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 2.61 0.17 Bn
206 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn 2.69 -0.02 Bn
207 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.18 Bn
208 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
209 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
210 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
211 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn 60.95 0.19 Bn
212 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn — 0.00 Bn
213 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn 2.74 0.04 Bn
214 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn 7.70 0.16 Bn
215 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn — — 0.00 Bn
216 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn — 0.17 Bn
217 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 28.43 0.16 Bn
218 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 32.99 0.16 Bn
219 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn — 0.14 Bn
220 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 12.81 0.12 Bn
221 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 1,882.13 -0.04 Bn
222 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
223 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn — — -0.02 Bn
224 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
225 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn 1,384.00 0.14 Bn
226 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn — 0.13 Bn
227 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn — 0.13 Bn
228 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn 132.26 0.13 Bn
229 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn 37.36 0.10 Bn
230 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn 41.31 0.12 Bn
231 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.01 Bn
232 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.11 Bn
233 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.06 Bn
234 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn — 0.11 Bn
235 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn — 0.11 Bn
236 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn 13.36 0.06 Bn
237 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.10 Bn
238 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.08 Bn
239 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn 148.74 0.10 Bn
240 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
241 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
242 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
243 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
244 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
245 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
246 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 1.25 -0.11 Bn
247 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
248 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 55.22 0.09 Bn
249 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.06 Bn
250 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
251 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.05 Bn
252 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
253 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.07 Bn
254 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 123.88 0.07 Bn
255 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.07 Bn
256 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 1.47 0.02 Bn
257 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.07 Bn
258 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 0.44 0.02 Bn
259 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 3.30 -0.05 Bn
260 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 16.88 0.03 Bn
261 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn — 0.06 Bn
262 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 28.87 0.05 Bn
263 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 5.23 0.00 Bn
264 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 1,478.69 0.05 Bn
265 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
266 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 3.93 0.05 Bn
267 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
268 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 294.15 -0.01 Bn
269 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.02 Bn
270 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 2.18 0.05 Bn
271 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 334.00 0.02 Bn
272 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
273 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
274 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 83.60 0.04 Bn
275 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
276 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 4.72 0.04 Bn
277 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
278 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.03 Bn
279 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 4.54 0.06 Bn
280 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
281 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.94 0.02 Bn
282 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.93 0.03 Bn
283 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
284 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.35 0.03 Bn
285 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
286 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
287 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
288 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 93.50 0.03 Bn
289 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 37.34 0.03 Bn
290 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
291 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
292 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
293 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 755.61 0.02 Bn
294 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
295 GRDX GridAI Technologies Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 239.09 0.02 Bn
296 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
297 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 2.62 0.02 Bn
298 CNSY Cerenome, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 4.66 0.01 Bn
299 KTTA Pasithea Therapeutics Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
300 DYAI Dyadic International Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 4.84 0.02 Bn